You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HPV16

Showing 1 - 25 of 900
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HSIL of Cervix Trial in Heze (NWRD08)

Recruiting
  • HSIL of Cervix
  • NWRD08
  • Heze, Shandong, China
    Heze Municipal Hospital
Jun 6, 2023

Oropharynx Squamous Cell Carcinoma Trial (HPV16 Ct-DNA dosing)

Not yet recruiting
  • Oropharynx Squamous Cell Carcinoma
  • HPV16 Ct-DNA dosing
  • (no location specified)
Oct 13, 2022

HPV Infection, HPV-Related Cervical Carcinoma Trial (FluBHPVE6E7, Placebo)

Not yet recruiting
  • HPV Infection
  • HPV-Related Cervical Carcinoma
  • FluBHPVE6E7
  • Placebo
  • (no location specified)
Apr 24, 2023

Recurrent Human Papillomavirus Type 16 Associated Cancer Trial in Birmingham, Baltimore (HPV 16 TA-CIN)

Withdrawn
  • Recurrent Human Papillomavirus Type 16 Associated Cancer
  • HPV 16 TA-CIN
  • Birmingham, Alabama
  • +1 more
Nov 29, 2022

HPV 16+ Recurrent or Metastatic Cancer Trial (CD8 reduced peripheral blood cells taken from related donors vaccinated against

Not yet recruiting
  • HPV 16+ Recurrent or Metastatic Cancer
  • CD8 reduced peripheral blood cells taken from related donors vaccinated against HPV16
  • Non-myeloablative allogeneic bone marrow transplant from related donors vaccinated against HPV16
  • (no location specified)
Jun 27, 2022

Solid Tumor Trial in Wuhan (HPV-T, Interleukin-2)

Recruiting
  • Solid Tumor
  • Wuhan, Hubei, China
    Wuhan Union Hospital
May 31, 2023

HPV-associated Oropharyngeal Cancer

Recruiting
  • PREDICTIVE BIOMARKERS
  • +2 more
  • HPV-ASSOCIATED OROPHARYNGEAL CANCER
  • Rome, Italy
    "Regina Elena" National Cancer Institute
Oct 19, 2023

Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Human Papillomavirus-Related Carcinoma, Locally

Recruiting
  • Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
  • +5 more
  • Liposomal HPV-16 E6/E7 Multipeptide Vaccine PDS0101
  • Pembrolizumab
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 4, 2023

CIN3, Cervical Intraepithelial Neoplasia, Cervical Intraepithelial Neoplasia Grade 3 Trial in Groningen (Vvax001 therapeutic

Recruiting
  • CIN3
  • +3 more
  • Vvax001 therapeutic cancer vaccine
  • Groningen, Netherlands
    University Medical Center Groningen (UMCG)
Aug 23, 2023

HPV-Related Cervical Carcinoma, HPV-Related Malignancy, Cervical Cancer Trial (VB10.16, Atezolizumab Injection [Tecentriq],

Not yet recruiting
  • HPV-Related Cervical Carcinoma
  • +2 more
  • VB10.16
  • +2 more
  • (no location specified)
Oct 24, 2023

Adult Solid Tumor Trial in Scottsdale, Aurora, Nashville (SQZ-eAPC-HPV, Pembrolizumab)

Recruiting
  • Adult Solid Tumor
  • SQZ-eAPC-HPV
  • Pembrolizumab
  • Scottsdale, Arizona
  • +4 more
Jan 26, 2023

Cervical Carcinoma Trial in Chongqing (TC-E202 cells, IL-2, Fludarabine)

Recruiting
  • Cervical Carcinoma
  • TC-E202 cells
  • +3 more
  • Chongqing, Chongqing, China
    Xiaochun Cheng
Oct 20, 2022

Human Papilloma Virus, HPV, HPV Positive Oropharyngeal Squamous Cell Carcinoma Trial in Chicago (HB-201, HB-202, Carboplatin)

Recruiting
  • Human Papilloma Virus
  • +3 more
  • Chicago, Illinois
    University of Chicago
Aug 11, 2022

Cervical Intraepithelial Neoplasia Grade I/ II/ III (CIN I/II/III), Human Papillomavirus (HPV) Infections, High-risk HPV Trial

Recruiting
  • Cervical Intraepithelial Neoplasia Grade I/ II/ III (CIN I/II/III)
  • +3 more
  • Nonavalent HPV vaccine (9vHPV/Gardasil-9™).
  • L'Hospitalet De Llobregat, Catalunya, Spain
    Gynaecology Unit, Bellvitge University Hospital (HUB)
Jan 24, 2023

HPV 16+ Confirmed Oropharynx Cancer and Cervical Cancer Trial in Milwaukee (HB-201 IT, HB-201 IV)

Recruiting
  • HPV 16+ Confirmed Oropharynx Cancer and Cervical Cancer
  • HB-201 IT
  • HB-201 IV
  • Milwaukee, Wisconsin
    Froedtert Hospital and the Medical College of Wisconsin
Jul 28, 2022

HPV-Related Squamous Cell Carcinoma, HNSCC Trial in London (VB10.16, Pembrolizumab)

Not yet recruiting
  • HPV-Related Squamous Cell Carcinoma
  • HNSCC
  • London, United Kingdom
    East and North Hertfordshire NHS Trust Mount Vernon Hospital
Aug 24, 2023

HPV16 Associated Cervical Cancer Trial in Birmingham, Baltimore (TA-CIN (arm), TA-CIN (thigh))

Active, not recruiting
  • HPV16 Associated Cervical Cancer
  • TA-CIN (arm)
  • TA-CIN (thigh)
  • Birmingham, Alabama
  • +1 more
Jul 22, 2022

Oropharyngeal Cancer, Human Papilloma Virus, Head Neck Cancer Trial (Fludarabine, Cyclophosphamide, NEXI-003 T cells)

Not yet recruiting
  • Oropharyngeal Cancer
  • +10 more
  • (no location specified)
Dec 14, 2022

CZ Using the Detection of HPV DNA and CINtec Plus

Completed
  • Algorithm for Cervix Carcinoma Screening
  • HPV DNA test with selective HPV 16/18 genotyping (cobas® 4800 HPV Test, Roche)
  • +2 more
  • Praha, Czech Republic, Czechia
    Aeskulab Patologie, ks
Oct 11, 2022

Oropharyngeal Squamous Cell Carcinoma Trial in Saint Louis (CUE-101)

Recruiting
  • Oropharyngeal Squamous Cell Carcinoma
  • Saint Louis, Missouri
    Washington University School of Medicine
Nov 22, 2022

Human Papillomavirus in Young People Epidemiological Research 3

Not yet recruiting
  • Human Papillomavirus Infection
  • +6 more
    • (no location specified)
    Oct 17, 2022

    Adult Solid Tumor Trial in Spain, United States (SQZ-AAC-HPV, Ipilimumab, Nivolumab)

    Recruiting
    • Adult Solid Tumor
    • SQZ-AAC-HPV
    • +2 more
    • Duarte, California
    • +5 more
    Aug 12, 2022

    Malignant Tumors of Ill-defined Secondary and Unspecified Sites, Malignant Tumors of Lip Oral Cavity and Pharynx, Oropharyngeal

    Terminated
    Has Results
    • Malignant Neoplasms of Ill-defined Secondary and Unspecified Sites
    • +2 more
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Nov 22, 2022

    Human Papillomavirus in Young People Epidemiological Research 4

    Not yet recruiting
    • Human Papillomavirus Infection
    • +6 more
      • (no location specified)
      Oct 17, 2022

      Will Permit Sites to Proactively Assess TAA, HLA and HPV-16

      Terminated
      • Head and Neck Cancer
      • +7 more
      • Tumor Profiling
      • Scottsdale, Arizona
      • +2 more
      Dec 2, 2022